Literature DB >> 21315738

Role of decoy molecules in neuronal ischemic preconditioning.

Mathivadhani Panneerselvam1, Piyush M Patel, David M Roth, Michael W Kidd, Blake Chin-Lee, Brian P Head, Ingrid R Niesman, Satoki Inoue, Hemal H Patel, Daniel P Davis.   

Abstract

AIMS: Decoy receptors bind with TNF related apoptosis inducing ligands (TRAIL) but do not contain the cytoplasmic domains necessary to transduce apoptotic signals. We hypothesized that decoy receptors may confer neuronal protection against lethal ischemia after ischemic preconditioning (IPC). MAIN
METHOD: Mixed cortical neurons were exposed to IPC one day prior to TRAIL treatment or lethal ischemia. KEY
FINDINGS: IPC increased decoy receptor but reduced death receptor expression compared to lethal ischemia. IPC-induced increase in decoy receptor expression was reduced by prior treatment with CAPE, a nuclear factor-kappa B inhibitor (NFκB). SIGNIFICANCE: Expression of decoy molecules, dependent on NFκB, may mediate neuronal survival induced by IPC.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21315738      PMCID: PMC3070046          DOI: 10.1016/j.lfs.2011.02.004

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  16 in total

1.  Multiple sclerosis: death receptor expression and oligodendrocyte apoptosis in established lesions.

Authors:  Barbara Cannella; Stefanie Gaupp; Kakuri M Omari; Cedric S Raine
Journal:  J Neuroimmunol       Date:  2007-07-05       Impact factor: 3.478

2.  Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand.

Authors:  M Jo; T H Kim; D W Seol; J E Esplen; K Dorko; T R Billiar; S C Strom
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

3.  Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.

Authors:  Delphine Mérino; Najoua Lalaoui; Alexandre Morizot; Pascal Schneider; Eric Solary; Olivier Micheau
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

4.  Hypoxia-induced decoy receptor 2 gene expression is regulated via a hypoxia-inducible factor 1alpha-mediated mechanism.

Authors:  Guo-Ting Pei; Chi-Wei Wu; Wan-Wan Lin
Journal:  Biochem Biophys Res Commun       Date:  2009-12-17       Impact factor: 3.575

5.  Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.

Authors:  Peter Mu-Hsin Chang; Po-Min Chen; Shie-Liang Hsieh; Cheng-Hwai Tzeng; Jin-Hwang Liu; Tzeon-Jye Chiou; Wei-Shu Wang; Chueh-Chuan Yen; Jyh-Pyng Gau; Muh-Hwa Yang
Journal:  Int J Oncol       Date:  2008-09       Impact factor: 5.650

6.  Death receptor-4 (DR4) expression is regulated by transcription factor NF-kappaB in response to etoposide treatment.

Authors:  Francisco José Mendoza; Ganchimeg Ishdorj; Xiaojie Hu; Spencer B Gibson
Journal:  Apoptosis       Date:  2008-06       Impact factor: 4.677

7.  Proteasome inhibitors enhance TRAIL-induced apoptosis through the intronic regulation of DR5: involvement of NF-kappa B and reactive oxygen species-mediated p53 activation.

Authors:  Jun-Jie Chen; Chia-Wei Chou; Yu-Fan Chang; Ching-Chow Chen
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

8.  CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL.

Authors:  Marion Travert; Patricia Ame-Thomas; Céline Pangault; Alexandre Morizot; Olivier Micheau; Gilbert Semana; Thierry Lamy; Thierry Fest; Karin Tarte; Thierry Guillaudeux
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

9.  FLIP(L) protects neurons against in vivo ischemia and in vitro glucose deprivation-induced cell death.

Authors:  Era Taoufik; Samuel Valable; Georg J Müller; Michael L Roberts; Didier Divoux; Antoine Tinel; Anda Voulgari-Kokota; Vivian Tseveleki; Fiorella Altruda; Hans Lassmann; Edwige Petit; Lesley Probert
Journal:  J Neurosci       Date:  2007-06-20       Impact factor: 6.167

10.  Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis.

Authors:  Lauren Clancy; Karen Mruk; Kristina Archer; Melissa Woelfel; Juthathip Mongkolsapaya; Gavin Screaton; Michael J Lenardo; Francis Ka-Ming Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-30       Impact factor: 11.205

View more
  6 in total

1.  Survival of aging CD264+ and CD264- populations of human bone marrow mesenchymal stem cells is independent of colony-forming efficiency.

Authors:  Sean D Madsen; Sean H Jones; H Alan Tucker; Margaret K Giler; Dyllan C Muller; Carson T Discher; Katie C Russell; Georgina L Dobek; Mimi C Sammarco; Bruce A Bunnell; Kim C O'Connor
Journal:  Biotechnol Bioeng       Date:  2019-11-12       Impact factor: 4.530

2.  Ischemic Preconditioning Upregulates Decoy Receptors to Protect SH-SY5Y Cells from OGD Induced Cellular Damage by Inhibiting TRAIL Pathway and Agitating PI3K/Akt Pathway.

Authors:  Wei Jin; Wei Xu; Xiaoxiao Zhang; Chuan-Cheng Ren
Journal:  Mol Neurobiol       Date:  2020-06-20       Impact factor: 5.590

3.  Remote Limb Preconditioning Generates a Neuroprotective Effect by Modulating the Extrinsic Apoptotic Pathway and TRAIL-Receptors Expression.

Authors:  Wei Xu; Wei Jin; Xiaoxiao Zhang; Jing Chen; Chuancheng Ren
Journal:  Cell Mol Neurobiol       Date:  2016-03-14       Impact factor: 5.046

Review 4.  Clinical perspectives of TRAIL: insights into central nervous system disorders.

Authors:  Veronica Tisato; Arianna Gonelli; Rebecca Voltan; Paola Secchiero; Giorgio Zauli
Journal:  Cell Mol Life Sci       Date:  2016-02-24       Impact factor: 9.261

Review 5.  Insight into the divergent role of TRAIL in non-neoplastic neurological diseases.

Authors:  Shiqi Gao; Yuanjian Fang; Sheng Tu; Huaijun Chen; Anwen Shao
Journal:  J Cell Mol Med       Date:  2020-08-22       Impact factor: 5.310

6.  Ischemic tolerance modulates TRAIL expression and its receptors and generates a neuroprotected phenotype.

Authors:  G Cantarella; G Pignataro; G Di Benedetto; S Anzilotti; A Vinciguerra; O Cuomo; G F Di Renzo; C Parenti; L Annunziato; R Bernardini
Journal:  Cell Death Dis       Date:  2014-07-17       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.